The global Durvalumab market size was valued at US$ 2.34 billion in 2024 and is projected to reach US$ 4.57 billion by 2030, at a CAGR of 11.8% during the forecast period 2024-2030.
United States Durvalumab market size was valued at US$ 765 million in 2024 and is projected to reach US$ 1.43 billion by 2030, at a CAGR of 11.0% during the forecast period 2024-2030.
A human immunoglobulin G1 kappa (IgG1?) monoclonal antibody that blocks PD-L1.
Rapid growth driven by success in lung cancer treatment, particularly in stage III NSCLC. Expanding indications in bladder cancer and other tumor types. Ongoing trials in combination therapies for various cancers.
Report Overview
This report provides a deep insight into the global Durvalumab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Durvalumab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Durvalumab market in any manner.
Global Durvalumab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Market Segmentation (by Type)
- 2.4mL Injection
- 10mL Injection
Market Segmentation (by Application)
- Locally Advanced Urothelial Carcinoma
- Metastatic Urothelial Carcinoma
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Durvalumab Market
- Overview of the regional outlook of the Durvalumab Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Durvalumab
1.2 Key Market Segments
1.2.1 Durvalumab Segment by Type
1.2.2 Durvalumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Durvalumab Market Overview
2.1 Global Market Overview
2.1.1 Global Durvalumab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Durvalumab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Durvalumab Market Competitive Landscape
3.1 Global Durvalumab Sales by Manufacturers (2019-2024)
3.2 Global Durvalumab Revenue Market Share by Manufacturers (2019-2024)
3.3 Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Durvalumab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Durvalumab Sales Sites, Area Served, Product Type
3.6 Durvalumab Market Competitive Situation and Trends
3.6.1 Durvalumab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Durvalumab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Durvalumab Industry Chain Analysis
4.1 Durvalumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Durvalumab Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Durvalumab Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Durvalumab Sales Market Share by Type (2019-2024)
6.3 Global Durvalumab Market Size Market Share by Type (2019-2024)
6.4 Global Durvalumab Price by Type (2019-2024)
7 Durvalumab Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Durvalumab Market Sales by Application (2019-2024)
7.3 Global Durvalumab Market Size (M USD) by Application (2019-2024)
7.4 Global Durvalumab Sales Growth Rate by Application (2019-2024)
8 Durvalumab Market Segmentation by Region
8.1 Global Durvalumab Sales by Region
8.1.1 Global Durvalumab Sales by Region
8.1.2 Global Durvalumab Sales Market Share by Region
8.2 North America
8.2.1 North America Durvalumab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Durvalumab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Durvalumab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Durvalumab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Durvalumab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Medimmune (AstraZeneca)
9.1.1 Medimmune (AstraZeneca) Durvalumab Basic Information
9.1.2 Medimmune (AstraZeneca) Durvalumab Product Overview
9.1.3 Medimmune (AstraZeneca) Durvalumab Product Market Performance
9.1.4 Medimmune (AstraZeneca) Business Overview
9.1.5 Medimmune (AstraZeneca) Durvalumab SWOT Analysis
9.1.6 Medimmune (AstraZeneca) Recent Developments
10 Durvalumab Market Forecast by Region
10.1 Global Durvalumab Market Size Forecast
10.2 Global Durvalumab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Durvalumab Market Size Forecast by Country
10.2.3 Asia Pacific Durvalumab Market Size Forecast by Region
10.2.4 South America Durvalumab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Durvalumab by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Durvalumab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Durvalumab by Type (2025-2030)
11.1.2 Global Durvalumab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Durvalumab by Type (2025-2030)
11.2 Global Durvalumab Market Forecast by Application (2025-2030)
11.2.1 Global Durvalumab Sales (Kilotons) Forecast by Application
11.2.2 Global Durvalumab Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Durvalumab Market Size Comparison by Region (M USD)
Table 5. Global Durvalumab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Durvalumab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Durvalumab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Durvalumab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Durvalumab as of 2022)
Table 10. Global Market Durvalumab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Durvalumab Sales Sites and Area Served
Table 12. Manufacturers Durvalumab Product Type
Table 13. Global Durvalumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Durvalumab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Durvalumab Market Challenges
Table 22. Global Durvalumab Sales by Type (Kilotons)
Table 23. Global Durvalumab Market Size by Type (M USD)
Table 24. Global Durvalumab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Durvalumab Sales Market Share by Type (2019-2024)
Table 26. Global Durvalumab Market Size (M USD) by Type (2019-2024)
Table 27. Global Durvalumab Market Size Share by Type (2019-2024)
Table 28. Global Durvalumab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Durvalumab Sales (Kilotons) by Application
Table 30. Global Durvalumab Market Size by Application
Table 31. Global Durvalumab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Durvalumab Sales Market Share by Application (2019-2024)
Table 33. Global Durvalumab Sales by Application (2019-2024) & (M USD)
Table 34. Global Durvalumab Market Share by Application (2019-2024)
Table 35. Global Durvalumab Sales Growth Rate by Application (2019-2024)
Table 36. Global Durvalumab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Durvalumab Sales Market Share by Region (2019-2024)
Table 38. North America Durvalumab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Durvalumab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Durvalumab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Durvalumab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Durvalumab Sales by Region (2019-2024) & (Kilotons)
Table 43. Medimmune (AstraZeneca) Durvalumab Basic Information
Table 44. Medimmune (AstraZeneca) Durvalumab Product Overview
Table 45. Medimmune (AstraZeneca) Durvalumab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Medimmune (AstraZeneca) Business Overview
Table 47. Medimmune (AstraZeneca) Durvalumab SWOT Analysis
Table 48. Medimmune (AstraZeneca) Recent Developments
Table 49. Global Durvalumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 50. Global Durvalumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 51. North America Durvalumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 52. North America Durvalumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 53. Europe Durvalumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 54. Europe Durvalumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 55. Asia Pacific Durvalumab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Asia Pacific Durvalumab Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. South America Durvalumab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. South America Durvalumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Middle East and Africa Durvalumab Consumption Forecast by Country (2025-2030) & (Units)
Table 60. Middle East and Africa Durvalumab Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Global Durvalumab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 62. Global Durvalumab Market Size Forecast by Type (2025-2030) & (M USD)
Table 63. Global Durvalumab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 64. Global Durvalumab Sales (Kilotons) Forecast by Application (2025-2030)
Table 65. Global Durvalumab Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Durvalumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Durvalumab Market Size (M USD), 2019-2030
Figure 5. Global Durvalumab Market Size (M USD) (2019-2030)
Figure 6. Global Durvalumab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Durvalumab Market Size by Country (M USD)
Figure 11. Durvalumab Sales Share by Manufacturers in 2023
Figure 12. Global Durvalumab Revenue Share by Manufacturers in 2023
Figure 13. Durvalumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Durvalumab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Durvalumab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Durvalumab Market Share by Type
Figure 18. Sales Market Share of Durvalumab by Type (2019-2024)
Figure 19. Sales Market Share of Durvalumab by Type in 2023
Figure 20. Market Size Share of Durvalumab by Type (2019-2024)
Figure 21. Market Size Market Share of Durvalumab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Durvalumab Market Share by Application
Figure 24. Global Durvalumab Sales Market Share by Application (2019-2024)
Figure 25. Global Durvalumab Sales Market Share by Application in 2023
Figure 26. Global Durvalumab Market Share by Application (2019-2024)
Figure 27. Global Durvalumab Market Share by Application in 2023
Figure 28. Global Durvalumab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Durvalumab Sales Market Share by Region (2019-2024)
Figure 30. North America Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Durvalumab Sales Market Share by Country in 2023
Figure 32. U.S. Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Durvalumab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Durvalumab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Durvalumab Sales Market Share by Country in 2023
Figure 37. Germany Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Durvalumab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Durvalumab Sales Market Share by Region in 2023
Figure 44. China Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Durvalumab Sales and Growth Rate (Kilotons)
Figure 50. South America Durvalumab Sales Market Share by Country in 2023
Figure 51. Brazil Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Durvalumab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Durvalumab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Durvalumab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Durvalumab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Durvalumab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Durvalumab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Durvalumab Market Share Forecast by Type (2025-2030)
Figure 65. Global Durvalumab Sales Forecast by Application (2025-2030)
Figure 66. Global Durvalumab Market Share Forecast by Application (2025-2030)
